Skip to main content

STN 50 mg Pill - brown capsule/oblong

Pill with imprint STN 50 mg is Brown, Capsule/Oblong and has been identified as Sunitinib Malate 50 mg. It is supplied by Novugen Pharma (USA) LLC.

Sunitinib is used in the treatment of Renal Cell Carcinoma; Gastrointestinal Stromal Tumor; Pancreatic Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for STN 50 mg

Sunitinib Malate

Imprint
STN 50 mg
Strength
50 mg
Color
Brown (caramel opaque cap and caramel opaque body)
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novugen Pharma (USA) LLC
National Drug Code (NDC)
82293-0017

Get help with Imprint Code FAQs.

Related images for "STN 50 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.